U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Nanotechnology Programs at FDA
  5. Office of Regulatory Affairs Nanotechnology Programs
  1. Nanotechnology Programs at FDA

Office of Regulatory Affairs Nanotechnology Programs

The Office of Regulatory Affairs (ORA) is charged with ensuring that FDA-regulated products that contain nanomaterials or otherwise utilize nanotechnology comply with current regulations and statutory requirements. This is typically accomplished by a variety of regulatory mechanisms, including the utilization of three key components: Investigations, Compliance, and the National Laboratory Resource. ORA is providing its scientists with the infrastructure and resources to address the questions raised by nanotechnology, such as effects on manufacture, quality control, and physical characterization of materials.

ORA’s Arkansas Regional Lab (ORA/ARL) and the Winchester Engineering and Analytical Center (ORA/WEAC) are collaborating with other FDA Centers (e.g., NCTR), federal agencies, academic institutions and private industry to enhance ORA’s regulatory science research important for compliance and enforcement determinations in FDA-regulated products. Current ORA nanotechnology regulatory science research focuses primarily on development of screening methodologies for the detection of nanomaterials in FDA-regulated products

For further information:

Office of Regulatory Affairs
Division of Field Science
12420 Parklawn Drive
Rockville, MD 20857
Telephone: 301-796-6600

Back to Top